Jon Hamrick, partner at Curatio Advisors, discusses how product attributes, company size and stakeholder alignment shape pharma commercialization strategy. Curatio Advisors starts its ...
The rule targets PBMs, but rebate, price protection and formulary deals they strike with drugmakers will be disclosed to plan fiduciaries and open to audit. Executive Order 14273, signed April 15, ...
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a ...
Why outdated paper prescribing information is creating unnecessary cost, complexity and friction across a modern ...
Anthony “TJ” Rizzo, chief commercial officer, Cold Chain Technologies, shares what steps the industry should take to prepare the next generation of cold chain operators.
At LogiPharma USA 2026, Mark Talens explains how end-to-end visibility lets pharma see its value chain across functions, and where supply chain monitoring is headed next. Mark Talens, chief commercial ...
EVERSANA is folding Estima Scientific's AI-powered HEOR tools into its market access offerings as its CEO says evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results